David B. Elsbree, Director at T2 Biosystems, Inc. (TTOO), bought 75 shares at $13.09 ($982) on 2015-08-07, disclosed to the SEC on 2015-08-11.
Open-market purchase of $982 TTOO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| TTOO | SELL | 2019-06-13 | $5K | — | Filing → |
| TTOO | BUY | 2018-06-05 | $32K | — | Filing → |
| TTOO | BUY | 2017-11-17 | $6K | — | Filing → |